Clevidipine in the treatment of perioperative hypertension: Assessing safety events in the ECLIPSE trials

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 5, 2009, Pages 465-472

  Aronson, Solomon ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antihypertensive; Blood pressure; Calcium antagonist; Calcium channel blocker; Cardiac surgery; Clevidipine; Coronary artery bypass grafting; Dihydropyridine; Hypertension; Nitroglycerin; Nitroprusside; Perioperative; Valve surgery

Indexed keywords

CLEVIDIPINE; GLYCERYL TRINITRATE; NICARDIPINE; NITROPRUSSIDE SODIUM; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; PYRIDINE DERIVATIVE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MORTALITY; PERIOPERATIVE HYPERTENSION; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ACUTE DISEASE; AGED; COMPARATIVE STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE COMPLICATIONS; MALE; NICARDIPINE; NITROGLYCERIN; NITROPRUSSIDE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PYRIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68949219470     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.1     Document Type: Article

References (54)

1. Leslie JB. Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol. Scand. Suppl. 99, 5-9 (1993).
2. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 131(6), 1949-1962 (2007).
3. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6), 1206-1252 (2003).
4. Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J. Card. Surg. 21 (Suppl. 1), S8-S14 (2006).
5. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5), E69-171 (2007).
6. National Center for Health Statistics (US), US Department of Health and Human Services, Centers for Disease Control and Prevention. Health, United States, 2005, with Chartbook on Trends in the Health of Americans with Special Feature on Drugs. US Government Printing Office, DC, USA (2007).
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290(2), 199-206 (2003).
8. Kearse LA Jr, Rosow C, Zaslavsky A, Connors, P, Dershwitz M, Denman W. Bispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis. Anesthesiology 88 (1), 25-34 (1998).
9. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25(3), 305-313 (1995).
10. Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26(1), 60-69 (1995).
11. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am. J. Public Health 78(6), 676-679 (1988).
12. Biller J, Feinberg WM, Castaldo JE et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 97(5), 501-509 (1998).
13. Atnip RG. Commentary. Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. Perspect. Vasc. Surg. Endovasc. Ther. 17(4), 379-381 (2005).
14. Aronson S, Dyke CM, Stierer KA et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth. Analg. 107(4), 1110-1121 (2008).
15. Skydell JL, Machleder HI, Baker JD, Busuttil RW, Moore WS. Incidence and mechanism of post-carotid endarterectomy hypertension. Arch. Surg. 122(10), 1153-1155 (1987).
16. Haas CE, LeBlanc JM. Acute postoperative hypertension: a review of therapeutic options. Am. J. Health Syst. Pharm. 61(16), 1661-1673 (2004).
17. Dix P, Howell S. Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery. Br. J. Anaesth. 86(6), 789-793 (2001).
18. Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth. Analg. 94(5), 1079-1084 (2002).
19. Reich DL, Bennett-Guerrero E, Bodian CA, Hossain S, Winfree W, Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth. Analg. 95(2), 273-277 (2002).
20. Weiss SJ, Longnecker DE. Perioperative hypertension: an overview. Coron. Artery Dis. 4(5), 401-406 (1993).
21. Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology 93 (1), 48-54 (2000).
22. Viljoen JF, Estafanous FG, Tarazi RC. Acute hypertension immediately after coronary artery surgery. J. Thorac. Cardiovasc. Surg. 71(4), 548-550 (1976).
23. Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, Shires GT. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann. Surg. 212(5), 567-580 (1990).
24. Charlson ME, MacKenzie CR, Gold JP et al. The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery. Ann. Surg. 210(5), 637-648 (1989).
25. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6(3), 167-178 (1999).
26. Hennein HA, Ebba H, Rodriguez JL et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg. 108(4), 626-635 (1994).
27. Herskowitz A, Mangano DT. Inflammatory cascade. A final common pathway for perioperative injury? Anesthesiology 85(5), 957-960 (1996).
28. Bailey JM, Lu W, Levy JH et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology 96(5), 1086-1094 (2002).
29. Ericsson H, Fakt C, Hoglund L et al. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers, after intravenous infusion. Eur. J. Clin. Pharmacol. 55(1), 61-67 (1999).
30. Ericsson H, Fakt C, Jolin-Mellgard A et al. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br. J. Clin. Pharmacol. 47(5), 531-538 (1999).
31. Nordlander M, Sjoquist PO, Ericsson H, Ryden L. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc. Drug Rev. 22(3), 227-250 (2004).
32. Halpern NA, Alicea M, Krakoff LR, Greenstein R. Postoperative hypertension: a prospective, placebo-controlled, randomized, double-blind trial, with intravenous nicardipine hydrochloride. Angiology 41(11 Pt 2), 992-1004 (1990).
33. Vuylsteke A, Feneck RO, Jolin-Mellgard A et al. Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. J. Cardiothorac. Vasc. Anesth. 14(3), 269-273 (2000).
34. Kieler-Jensen N, Jolin-Mellgard A, Nordlander M, Ricksten SE. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol. Scand. 44(2), 186-193 (2000).
35. Hartmann A, Buttinger C, Rommel T, Czernicki Z, Trtinjiak F. Alteration of intracranial pressure, cerebral blood flow, autoregulation and carbondioxide-reactivity by hypotensive agents in baboons with intracranial hypertension. Neurochirurgia (Stuttg.) 32(2), 37-43 (1989).
36. Kondo T, Brock M, Bach H. Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn. Heart J. 25(2), 231-237 (1984).
37. Griswold WR, Reznik V, Mendoza SA. Nitroprusside-induced intracranial hypertension. JAMA 246(23), 2679-2680 (1981).
38. Anile C, Zanghi F, Bracali A, Maira G, Rossi GF. Sodium nitroprusside and intracranial pressure. Acta Neurochir. (Wien.) 58(3-4), 203-211 (1981).
39. Mann T, Cohn PF, Holman LB, Green LH, Markis JE, Phillips DA. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation 57(4), 732-738 (1978).
40. Pasch T, Schulz V, Hoppelshauser G. Nitroprusside-induced formation of cyanide and its detoxication with thiosulfate during deliberate hypotension, J. Cardiovasc. Pharmacol. 5(1), 77-85 (1983).
41. Izumi Y, Benz AM, Clifford DB, Zorumski CF. Neurotoxic effects of sodium nitroprusside in rat hippocampal slices. Exp. Neurol. 121(1), 14-23 (1993).
42. Niknahad H, O'Brien PJ. Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity. Biochem. Pharmacol. 51(8), 1031-1039 (1996).
43. Higuchi S, Shiobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 10(6), 447-454 (1980).
44. Schillinger D. Nifedipine in hypertensive emergencies: a prospective study. J. Emerg. Med. 5(6), 463-473 (1987).
45. Haas AR, Marik PE. Current diagnosis and management of hypertensive emergency. Semin. Dial. 19(6), 502-512 (2006).
46. Nordlander M, Björkman JA, Regårdh CG, Thalen P. Pharmacokinetics and hemodynamic effects of an ultrashort-acting calcium antagonist. Br. J. Anaesth. 76(Suppl.), A24 (1996).
47. Powroznyk AV, Vuylsteke A, Naughton C et al. Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur. J. Anaesthesiol. 20(9), 697-703 (2003).
48. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19), 2560-2572 (2003).
49. Brooks TW, Finch CK, Lobo BL, Deaton PR, Varner CF. Blood pressure management in acute hypertensive emergency. Am. J. Health Syst. Pharm. 64(24), 2579-2582 (2007).
50. Kleinschmidt K, Granger C, Peacock WF et al. Acute severe hypertension - diverse management, high morbidity, and much death: results from the Stat Registry. Acad. Emerg. Med. 15(Suppl. 1), S60 (2008).
51. Granger C, Katz J, Kleinschmidt K et al. Acute severe hypertension is associated with high morbidity and mortality: interim results from the STAT registry. Presented at: Society of Critical Care Medicine (SCCM) 37th Annual Critical Care Congress. Honolulu, HI, USA, 2-6 February 2008 (Poster #651).
52. Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107(2), 213-220 (2007).
53. Williams B, Lacy PS, Thom SM et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113 (9), 1213-1225 (2006).
54. Schiffrin EL. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients? Circulation 112(11), 1525-1526 (2005).